NRBO - NeuroBo Pharmaceuticals Inc Price Chart

Graphic logo of NeuroBo Pharma (NRBO)

This price chart helps assess the growth trajectory of NeuroBo Pharmaceuticals (NRBO), which develops therapies for neurodegenerative disorders and metabolic pathologies. The current indicator stands at 2.38. Quotes are supported by successful trials of obesity and MASH treatments, as well as backing from major industry players. The company's stability is based on the development of liver disease medications in the US.

NRBO - NeuroBo Pharmaceuticals Price Chart over the range 07/04/2022 - 12/07/2024

NeuroBo (NRBO) - metric breakdowns and financial figures

- stock value and consensus price forecast:
Analysis of all company metrics:neurobopharma.com NRBO
Signature product of NeuroBo Pharmaceuticals Inc

The development of oral obesity treatments in collaboration with a Korean partner reduces R&D risks for NeuroBo Pharmaceuticals (NRBO), providing the asset with speculative potential. An analysis of historical quotes allows for an assessment of the business's market resilience through the amplitude of value fluctuations, where low volatility confirms the company's maturity, and price action serves as an indicator of the balance between capital attractiveness and expected investor returns.

Analysis of competing companies

Stock Price BIIB|Neurocrine Biosciences, Inc. - Share Price|Stock Price RGC (Regencell Bioscience Ltd)|AXSM: Share Price|ACADIA Corp - Stock Price|XENE (Xenon Pharmaceuticals) - Share Price|VKTX (Viking Pharma) - Stock Quotes|Share Price SUPN|Price Chart Catalyst Pharmaceuticals|Share Price DNLI (Denali Therapeutics Inc)|Stock Price HRMY|BHVN - Market Price|amylyx.com - Stock Quotes|Stock Price Trevi Therapeutics Inc TRVI|PRAX - Price Chart|Price Performance Chart AVXL (Anavex Life Sciences Corp)|CeriBell Inc (CBLL) - Price Chart|Market Price Prothena Corp (PRTA)|ALEC (Alector Therapeutics) - Stock Price|Stock Price Annexon Biosciences|Price Chart Omeros Corp (OMER)|NGNE - Market Price|AC Immune - Stock Quotes|Voyager Therapeutics (VYGR) - Market Price|NMRA - Price Chart|SCLX: Price Chart|TVGN: Stock Price|Alpha Cognition (ACOG) - Stock Price|Stock Quotes CGTX|Stock Price Inhibikase Therapeutics|Stock Price SAVA|Market Chart Assertio Holdings|Stock Price COYA (Coya Therapeutics)|VTGN: Share Price|OVID - Price Chart|Price Performance Chart ABOS (Acumen Pharmaceuticals)|CRVO: Stock Price|ATHE: Price|CLNN (clene.com) - Stock Price|pepgen.com (PEPG) - Market Chart|Price Chart Jupiter Neurosciences Inc (JUNS)|RLMD (Relmada Therapeutics) - Price Performance Chart|Stock Price ANVS (Annovis Bio Inc)|gracetx.com (GRCE) - Market Price|AIFF - Price Chart|anewmeds.com (KLTO) - Stock Quotes|NeuroSense Therapeutics, Ltd. (NRSN) - Price Chart|Market Price Reviva Pharmaceuticals Holdings, Inc. (RVPH)|Price Chart MetaVia|Share Price NRXS (NeurAxis Inc.)|Stock Price HSDT|PASG: Quote Chart|Neuphoria Therapeutics, Inc. - Stock Quotes|NERV: Share Price|athira.com - Stock Price|ADXN - Stock Price|ALZN: Stock Price|CYCN - Market Chart|PTIX (Protagenic Therapeutics, Inc.) - Stock Price|pasitheaclinics.com (KTTA) - Market Chart|Price Chart Cortigent Inc (CRGT)|Avenue Therapeutics, Inc. - Share Price|Price Chart Brainstorm Cell Therapeutics, Inc. BCLI|CARA - Stock Quotes|chromocell.com - Stock Price|Market Price Eliem Therapeutics, Inc.|ITCI: Stock Price|LBPH - Market Chart|Price Chart Marinus Pharmaceuticals|NKGN: Price Performance Chart|Price Chart Sage Therapeutics (SAGE)|Market Chart Synaptogenix|Stock Price TRVN (trevena.com)|Vigil Neuro - Price Chart|Anew Medical Inc. - Stock Price|Market Price Cerevel